News

New therapy for small cell lung cancer offered at Hollings

A doctor in a white coat sits to chat with a patient, who has her back facing the camera

A newly approved targeted therapy for small cell lung cancer patients whose cancer has not responded or stopped responding to chemotherapy is at the forefront of a new type of drug for solid tumors. The team at Hollings is already experienced at delivering the drug, called tarlatamab, having participated in an arm of the clinical trial.

“It will be incredible to have more drugs of this nature, which is where the oncology solid tumor field is moving,” said Mariam Alexander, M.D., Ph.D.

Read about the drug

a woman in bright pink headband, glasses and earring smiles in a garden setting

Surviving Lung Cancer

Faith and positivity - those are the things that have kept Cynthia Waddy going through the ups and downs of lung cancer treatment.

peering through shelving at a scientist in white coat and blue gloves concentrating on work in the lab

Catalyst Award

The American Cancer Society awarded Hollings researcher David Long, Ph.D., a Catalyst grant to study how two proteins' interaction affects genomic instability.

Dr. Joe Delaney in his MUSC Hollings lab

Tackling Cancer Resistance

Anti-malarial drug shows promise against cancer, but resistance often develops. A Hollings team found out how, setting stage for combination therapies.

an older couple poses under a brick pergola

Lung Cancer

"If you have life, you have hope," explains lung cancer survivor Juan Ramonell.

a word cloud in the shape of an apple with Quit Smoking being the most prominent and other words including life, muscle and more

Quitting Smoking after Cancer

Quitting smoking soon after a cancer diagnosis adds an average of two years to a patient's life, a new study finds.

a man and woman sit in an outdoor cafe and smile at the camera

Honoring Kathy

Mourning the loss of their wife and mother to astrocytoma, the Kopniskys have donated to research on brain tumors and are sponsors of LOWVELO.

a scientist in a white lab coat sits at the bench next to a microscope with a computer screen showing the image

Identifying Targets

A new study from MUSC Hollings Cancer Center shows how a receptor called PPAR δ helps disable the immune system so that T-cells can’t kill cancer cells.

image of young doctor in white coat standing outside a tall glass building

Called to Cancer Care

After twice surviving cancer, an internal medicine resident feels called to oncology.

two women in business casual attire pose in a garden setting

Cannabis and Cancer

Cancer patients who smoke cigarettes are more likely than nonsmokers to use cannabis, researchers find.